News


Published Thursday, September 27, 2012

SAN DIEGO, CA (September 27, 2012) – Freedom Meditech, Inc., developer of non-invasive ophthalmic products for the detection of disease and management of patient health, today announced it has secured a $2 million line of credit from Silicon Valley Bank (SVB). The funds will be used to ramp up manufacturing and distribution of the company's ClearPath more»



Published Saturday, July 28, 2012

It is hard to believe it is already July and time to report on Freedom-Meditech's many accomplishments in the first half of 2012.  We are on schedule to transfer the ClearPath DS-120 into manufacturing during the second half of 2012.

more»



Published Saturday, July 28, 2012

The ClearPath DS-120™ is staging for production and manufacturing this year.  The optical, mechanical, electrical, software, and industrial designs are all in the final stages of preparation for the transfer to manufacturing. It should be noted that we are fortunate

more»



Published Saturday, July 28, 2012

After completing a world-wide search for distributors, Freedom-Meditech has commenced the appointment of exclusive distributors on a country by country basis.  Freedom-Meditech has assembled an extensive “tool box” to support distributors with

more»



Published Saturday, July 28, 2012

The Food and Drug Administration’s (FDA) 510(k) market clearance of the ClearPath DS-120™ remains in process.  We have received multiple letters back from the FDA regarding our application, and in a positive sign

more»



Published Saturday, July 28, 2012

Freedom-Meditech has been actively pursuing a qualified Series B Equity investment for its ClearPath DS-120 and non-invasive glucose monitor product lines.  The past six (6) months, Freedom-Meditech presented or attended over a dozen investor conferences starting in January with the prestigious

 

more»



Published Monday, December 12, 2011

We are thrilled to introduce and distribute the first electronic Freedom Meditech newsletter.  There have been so many news worthy accomplishments at the company combined with the

more»



Published Monday, December 12, 2011

Freedom-Meditech has been on the road all over the world  to begin selection of distributors in contemplation of the commercialization of the ClearPath DS120.  Shows attended included the American Academy of Optometry, the American Academy of Optometry and MEDICA.  The take home value of attending these meetings is more»



Published Monday, December 12, 2011

On September 29th, 2011 Freedom-Meditech submitted a 510(k) application to the Food and Drug Administration for clearance to market in the United States.  The 510(k) submission process is based on

more»



Published Monday, December 12, 2011

Freedom-Meditech’s first advisory board meeting was held in October in Boston.  Four charter members attended the meeting.  The purpose of the Advisory Board

more»


Items 11-20 of 32